Dusa Pharmaceuticals (DUSA) is a vertically integrated dermatology that is developing and marketing Levulan photodynamic therapy. This stock is trading up 7.4% to $5.78 in recent trading.
Today's Range: $5.44-$5.8952-Week Range: $3.25-$6.62 Volume: 88,000 Three-Month Average Volume: 74,906 >>5 Stocks Ready to Get Squeezed Higher From a technical perspective, DUSA is ripping to the upside here right off its 50-day moving average of $5.45 with above-average volume. This move is quickly pushing DUSA within range of triggering a near-term breakout trade. That trade will hit once DUSA manages to clear some near-term overhead resistance levels of $5.77 to $5.91, and then $6.16 with high volume. At last check, DUSA has hit an intraday high of $5.88 and volume is just starting to eclipse its three-month average volume of 74,906 shares. Traders should now look for long-biased trades in DUSA as long as its trending above its 50-day, and then once it sustains a move or close above those breakout levels with volume that's near or above 74,906 shares. If that breakout triggers soon, then DUSA will have a great chance of re-testing or possibly taking out its next major overhead resistance levels at $6.62 to $6.83. If that $6.83 level gets taken out, then DUSA will hit a new three-year high, which is bullish technical price action. To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts